Signaling Pathway
Gavilimomab (ABX-CBL) is an IgM murine monoclonal antibody designed to target CD147, a cell surface antigen. This antibody facilitates cell death via complement-mediated lysis. It is primarily utilized in the study of graft-versus-host disease (GVHD), offering a valuable tool for researchers investigating the pathophysiology and potential therapeutic interventions of this condition.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Gavilimomab (ABX-CBL) is an IgM murine monoclonal antibody designed to target CD147, a cell surface antigen. This antibody facilitates cell death via complement-mediated lysis. It is primarily utilized in the study of graft-versus-host disease (GVHD), offering a valuable tool for researchers investigating the pathophysiology and potential therapeutic interventions of this condition. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
